Vaccine Upgrade Being Considered By BioNtech, Can Move Fast To Address Omicron Threat, Says CEO
BioNTech should be able to change its coronavirus vaccine swiftly in reaction to the Omicron variant, and the next few weeks will demonstrate how urgently an upgrade is required, according to BioNTech CEO Ugur Sahin, who spoke at the Reuters Next conference on Friday. People should continue to seek out the established injection, which was…








